Drugs Made In America Acquisition II Corp. - (DMII) closed at $10.21 on November 3, 2026, unchanged from the previous close, on volume of 1,580 shares (30-day average 170,752).
Data as of November 3, 2026.
No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition II Corp is a blank check Company.
Drugs Made In America Acquisition II Corp. - trades on the NASDAQ stock market under the symbol DMII.
As of November 4, 2026, DMII stock price climbed to $10.22 with 34,089 million shares trading.
DMII has a beta of 0.02, meaning it tends to be less sensitive to market movements. DMII has a correlation of 0.02 to the broad based SPY ETF.
DMII has a market cap of $651.01 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that DMII belongs to (by Net Assets): SPCK.
DMII support price is $10.20 and resistance is $10.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMII shares will trade within this expected range on the day.
